Alkermes has reached an agreement to buy Avadel Pharma in a deal valued at up to $2.1 billion, claiming rights to an ...
Onsite at ESMO 2025, pharmaphorum spoke with Adrian Jubb, head of oncology and neurology clinical development at Corcept, and ...
Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an ...
An oversubscribed seed funding round will give Procyon the financial resources it needs to launch its first diagnostic – ...
Ipsen has reached an agreement to buy fellow French firm ImCheck Therapeutics in a deal that could be worth up to €1 billion ...
Prior to joining CMI Media Group, Freid held positions at various SaaS tech start-ups and performance focused advertising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback